Adage Capital Partners Gp, L.L.C. Galera Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.27 - $8.28 $1.92 Million - $12.5 Million	-1,509,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.14 - $14.41 $1.43 Million - $2.88 Million	200,000 Added 15.27%	1,509,500 $10.8 Million
Q1 2020 May 15, 2020	BUY	$5.89 - $17.67 $55,955 - $167,865	9,500 Added 0.73%	1,309,500 $12.4 Million
Q4 2019 Feb 14, 2020	BUY	$9.13 - $13.9 $11.9 Million - $18.1 Million	1,300,000 New	1,300,000 $17.1 Million

961K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.34M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.